NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $569,653 | -1.5% | 5,593 | -2.4% | 0.11% | -0.9% |
| Q2 2023 | $578,215 | -2.6% | 5,730 | -11.2% | 0.11% | -4.5% |
| Q1 2023 | $593,861 | -9.8% | 6,455 | -11.0% | 0.11% | -15.8% |
| Q4 2022 | $658,175 | +17.7% | 7,255 | -1.4% | 0.13% | -0.7% |
| Q3 2022 | $559,000 | -10.1% | 7,359 | +0.1% | 0.13% | -7.6% |
| Q2 2022 | $622,000 | -47.6% | 7,355 | -45.6% | 0.14% | -38.8% |
| Q1 2022 | $1,187,000 | +1.0% | 13,528 | +0.7% | 0.24% | -6.0% |
| Q4 2021 | $1,175,000 | -10.5% | 13,428 | -16.4% | 0.25% | -45.7% |
| Q3 2021 | $1,313,000 | -16.5% | 16,056 | -6.8% | 0.46% | +23.7% |
| Q2 2021 | $1,572,000 | -6.6% | 17,227 | -85.6% | 0.38% | -9.4% |
| Q1 2021 | $1,683,000 | -66.1% | 119,438 | -24.3% | 0.41% | -71.8% |
| Q4 2020 | $4,964,000 | – | 157,675 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |